DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Infusion Pump Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA, Accessories), Application (Oncology, Diabetes, Gastroenterology, Analgesia, Pediatrics, Hematology) & End User (Hospital, Home care) - Global Forecast to 2021" report to their offering.
The global infusion pumps market is estimated to grow at a CAGR of 6.0% from 2016 to 2021, to reach USD 10.84 billion by 2021 from USD 8.12 billion in 2016.
Increasing prevalence of chronic diseases along with increasing geriatric population, increasing adoption of portable infusion pumps to reduce hospital expenditure, steady increase in surgical procedural volumes, and rising applications of infusion pumps in pain management are some of the key factors driving the growth of this market. However, patient safety risks and medication errors associated with infusion pumps leading to product recalls and stringent regulations for new products may restrict the growth of this market during the forecast period.
On the basis of product type, the infusion pumps market is segmented into devices and accessories. The Accessories segment is further segmented into dedicated and non-dedicated disposables. The dedicated disposables segment accounted for the largest share of the infusion pump accessories market in 2015. Devices segment is further subsegmented into volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps.
In 2015, the volumetric infusion pumps segment dominated the infusion pump devices market. The large share of this segment can be attributed to the increasing demand for volumetric infusion pumps in hospitals, long-term acute care centers, clinics, and ambulatory surgery centers.
- Rising Demand for Ambulatory Infusion Pumps
- Increasing Incidence of Chronic Diseases Along with the Rapid Growth in the Geriatric Population
- Growing Number of Surgical Procedures Performed
- Patient Safety Risks and Medication Errors Associated with Infusion Pumps Leading To Product Recalls
- Stringent Regulatory Requirements for New Products
- Increasing Demand for Infusion Pumps in Developing Economies
- Growing Adoption of Specialty Infusion Systems
- Increasing Incidence of Medication Errors and Lack of Wireless Connectivity in Most Hospitals
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company (BD)
- Fresenius SE & Co. Kgaa
- Johnson & Johnson
- Medtronic PLC
- Moog Inc.
- Pfizer Inc.
- Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
- Smiths Medical (A Division of Smiths Group PLC)
- Terumo Corporation
For more information about this report visit http://www.researchandmarkets.com/research/8ch6tl/infusion_pump